Veltrop M et al.A dystrophic Duchenne mouse model for testing human antisense oligonucleotides.PLoS One 13:e0193289 (2018).
PubMed: 29466448
Giacomazzi G et al.MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors.Nat Commun 8:1249 (2017).
PubMed: 29093487
Brinegar AE et al.Extensive alternative splicing transitions during postnatal skeletal muscle development are required for calcium handling functions.Elife 6:N/A (2017).
PubMed: 28826478
Giudice J et al.Neonatal cardiac dysfunction and transcriptome changes caused by the absence of Celf1.Sci Rep 6:35550 (2016).
WB
;
Mouse
.
PubMed: 27759042
Quijada P et al.Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment.J Biol Chem 290:25411-26 (2015).
WB
;
Mouse
.
PubMed: 26324717
Quattrocelli M et al.Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.J Clin Invest 125:4463-82 (2015).
WB
;
Mouse
.
PubMed: 26571398
Winter L et al.Plectin isoform P1b and P1d deficiencies differentially affect mitochondrial morphology and function in skeletal muscle.Hum Mol Genet 24:4530-44 (2015).
PubMed: 26019234
Verhaart IE et al.The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice.Mol Ther Nucleic Acids 3:e148 (2014).
WB
.
PubMed: 24549299
Giudice J et al.Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development.Nat Commun 5:3603 (2014).
WB
;
Mouse
.
PubMed: 24752171
Turnbull IC et al.Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.FASEB J 28:644-54 (2014).
IHC-P, IF
.
PubMed: 24174427
van Putten M et al.Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.FASEB J 27:2484-95 (2013).
PubMed: 23460734
van den Bergen JC et al.Clinical characterisation of Becker muscular dystrophy patients predicts favourable outcome in exon-skipping therapy.J Neurol Neurosurg Psychiatry N/A:N/A (2013).
Human
.
PubMed: 23667215
Veltrop M et al.Generation of embryonic stem cells and mice for duchenne research.PLoS Curr 5:N/A (2013).
WB
;
Mouse
.
PubMed: 24057032
van den Bergen JC et al.Dystrophin levels and clinical severity in Becker muscular dystrophy patients.J Neurol Neurosurg Psychiatry N/A:N/A (2013).
Human
.
PubMed: 24292997
Spitali P et al.DMD transcript imbalance determines dystrophin levels.FASEB J 27:4909-16 (2013).
PubMed: 23975932
Tanganyika-de Winter CL et al.Long-term Exon Skipping Studies With 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models.Mol Ther Nucleic Acids 1:e44 (2012).
PubMed: 23344236
Desroches BR et al.Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells.Am J Physiol Heart Circ Physiol 302:H2031-42 (2012).
IHC-Fr
;
Rat
.
PubMed: 22427522
Verhaart IE & Aartsma-Rus A The effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophy.PLoS Curr 4: (2012).
WB
;
Human
.
PubMed: 23259153
Spitalieri P et al.Identification of multipotent cytotrophoblast cells from human first trimester chorionic villi.Cloning Stem Cells 11:535-56 (2009).
IHC-P
;
Mouse
.
PubMed: 20025524
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"